Purification and characterization of NAD-dependent morphine 6-dehydrogenase from hamster liver cytosol, a new member of the aldo-keto reductase superfamily
T. Todaka et al., Purification and characterization of NAD-dependent morphine 6-dehydrogenase from hamster liver cytosol, a new member of the aldo-keto reductase superfamily, ARCH BIOCH, 374(2), 2000, pp. 189-197
Morphine 6-dehydrogenase, which catalyzes the dehydrogenation of morphine t
o morphine, was purified 815-fold to a homogeneous protein from the soluble
fraction of hamster liver with a yield of 15%. The enzyme was a monomeric
protein with a molecular weight of 38 kDa and an isoelectric point of 5.6.
Although both NAD and NADP served as cofactors, the enzyme activity with NA
DP was less than 5% that found with NAD at pH 7.4, With NAD, the enzyme gav
e the maximal activity at pH 9,3, and the K-m and V-max values toward morph
ine were 1.0 mM and 0.43 unit/mg protein, respectively. Among morphine cong
eners, normorphine exhibited higher activity than morphine, but codeine and
ethylmorphine were poor substrates, and dihydromorphine and dihydrocodeine
showed no detectable activity. The enzyme also exhibited significant activ
ity for a variety of cyclic and alicyclic alcohols. In addition to xenobiot
ics, the enzyme catalyzed the dehydrogenation of 17 beta-hydroxy-steroids w
ith much higher affinities than morphine. In the reverse reaction, the enzy
me exhibited high activity for o-quinones, but morphinone, naloxone, and ar
omatic ic aldehydes and ketones were reduced at slow rates, Sulfhydryl reag
ents and ketamine strongly inhibited the enzyme, whereas pyrazole, barbital
, and indomethacin had little effect on enzyme activity. 17 beta-Hydroxyste
roids inhibited the enzyme in a competitive manner against morphine. A tota
l of 302 amino acid residues, which comprised approximately 94% of whole pr
otein, were identified by sequencing of the peptides obtained by proteolyti
c digestion. This amino acid sequence of the enzyme showed significant homo
logy to members of the aldo-keto reductase (AKR) superfamily and shared 63-
64% identity with members of the AKR1C subfamily. These findings indicate t
hat the enzyme is a new member of the AKR superfamily that is involved in s
teroid metabolism as 17 beta-hydroxysteroid dehydrogenase as well as xenobi
otic metabolism. (C) 2000 Academic Press.